Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-25T21:09:22.947Z Has data issue: false hasContentIssue false
  • English
  • Français

Are remitted affective disorders and familial risk of affective disorders associated with metabolic syndrome, inflammation and oxidative stress? – a monozygotic twin study

Published online by Cambridge University Press:  04 September 2019

Ninja Meinhard Ottesen Open the ORCID record for Ninja Meinhard Ottesen [Opens in a new window] ,
Iselin Meluken ,
Ruth Frikke-Schmidt ,
Peter Plomgaard ,
Thomas Scheike ,
Brisa S. Fernandes ,
Michael Berk ,
Henrik Enghusen Poulsen ,
Lars Vedel Kessing  and
Kamilla Miskowiak
...Show all authors
Ninja Meinhard Ottesen*
Affiliation:
Copenhagen Affective Disorders Research Centre (CADIC), Psychiatric Center Copenhagen, Rigshospitalet, Copenhagen, Denmark
Iselin Meluken
Affiliation:
Copenhagen Affective Disorders Research Centre (CADIC), Psychiatric Center Copenhagen, Rigshospitalet, Copenhagen, Denmark
Ruth Frikke-Schmidt
Affiliation:
Department of Clinical Biochemistry Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Peter Plomgaard
Affiliation:
Department of Clinical Biochemistry Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Thomas Scheike
Affiliation:
Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark
Brisa S. Fernandes
Affiliation:
Centre for Addiction and Mental Health (CAMH) and Department of Psychiatry, University of Toronto, Toronto, ON, Canada
Michael Berk
Affiliation:
Deakin University, IMPACT Strategic Research Centre, School of Medicine, Geelong, Australia Orygen, the National Centre of Excellence in Youth Mental Health, the Florey Institute for Neuroscience and Mental Health, and the Department of Psychiatry, University of Melbourne, Parkville, Australia
Henrik Enghusen Poulsen
Affiliation:
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark Department of Clinical Pharmacology, Bispebjerg Frederiksberg Hospital, Copenhagen, Denmark
Lars Vedel Kessing
Affiliation:
Copenhagen Affective Disorders Research Centre (CADIC), Psychiatric Center Copenhagen, Rigshospitalet, Copenhagen, Denmark
Kamilla Miskowiak
Affiliation:
Copenhagen Affective Disorders Research Centre (CADIC), Psychiatric Center Copenhagen, Rigshospitalet, Copenhagen, Denmark
Maj Vinberg
Affiliation:
Copenhagen Affective Disorders Research Centre (CADIC), Psychiatric Center Copenhagen, Rigshospitalet, Copenhagen, Denmark
*
Author for correspondence: Ninja Meinhard Ottesen, E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Metabolic syndrome (MetS) is associated with reduced life expectancy in patients with affective disorders, however, whether MetS also plays a role before the onset of affective disorder is unknown. We aimed to investigate whether MetS, inflammatory markers or oxidative stress act as risk factors for affective disorders, and whether MetS is associated with increased inflammation and oxidative stress.

Methods

We conducted a high-risk study including 204 monozygotic (MZ) twins with unipolar or bipolar disorder in remission or partial remission (affected), their unaffected co-twins (high-risk) and twins with no personal or family history of affective disorder (low-risk). Metabolic Syndrome was ascertained according to the International Diabetes Federation (IDF) criteria. Inflammatory markers and markers of oxidative stress were analyzed from fasting blood and urine samples, respectively.

Results

The affected and the high-risk group had a significantly higher prevalence of MetS compared to the low-risk group (20% v. 15% v. 2.5%, p = 0.0006), even after adjusting for sex, age, smoking and alcohol consumption. No differences in inflammatory and oxidative markers were seen between the three groups. Further, MetS was associated with alterations in inflammatory markers, and oxidative stress was modestly correlated with inflammation.

Conclusion

Metabolic syndrome is associated with low-grade inflammation and may act as a risk factor and a trait marker for affective disorders. If confirmed in longitudinal studies, this suggests the importance of early intervention and preventive approaches targeted towards unhealthy lifestyle factors that may contribute to later psychopathology.

Keywords

Affective disorderinflammationmetabolic syndromemonozygotic twinsoxidative stressrisk factors
Type
Original Articles
Information
Psychological Medicine , Volume 50 , Issue 10 , July 2020 , pp. 1736 - 1745
Copyright
Copyright © Cambridge University Press 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Afari, N, Noonan, C, Goldberg, J, Roy-Byrne, P, Schur, E, Golnari, G and Buchwald, D (2010) Depression and obesity: do shared genes explain the relationship? Depression and Anxiety 27, 799–806.CrossRefGoogle ScholarPubMed
Amare, AT, Schubert, KO, Klingler-Hoffmann, M, Cohen-Woods, S and Baune, BT (2017) The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies. Translational Psychiatry 7, e1007.CrossRefGoogle ScholarPubMed
Baghai, TC, Varallo-Bedarida, G, Born, C, Hafner, S, Schule, C, Eser, D, Zill, P, Manook, A, Weigl, J, Jooyandeh, S, Nothdurfter, C, Von Schacky, C, Bondy, B and Rupprecht, R (2018) Classical risk factors and inflammatory biomarkers: one of the missing biological links between cardiovascular disease and major depressive disorder. International Journal of Molecular Sciences 19, 1740.CrossRefGoogle ScholarPubMed
Berk, M, Kapczinski, F, Andreazza, AC, Dean, OM, Giorlando, F, Maes, M, Yucel, M, Gama, CS, Dodd, S, Dean, B, Magalhaes, PV, Amminger, P, Mcgorry, P and Malhi, GS (2011) Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neuroscience & Biobehavioral Reviews 35, 804–817.CrossRefGoogle ScholarPubMed
Berk, M, Sarris, J, Coulson, CE and Jacka, FN (2013) Lifestyle management of unipolar depression. Acta psychiatrica Scandinavica. 127 Supplementum 443, 38–54.CrossRefGoogle Scholar
Broedbaek, K, Ribel-Madsen, R, Henriksen, T, Weimann, A, Petersen, M, Andersen, JT, Afzal, S, Hjelvang, B, Roberts, LJ II, Vaag, A, Poulsen, P and Poulsen, HE (2011) Genetic and environmental influences on oxidative damage assessed in elderly Danish twins. Free Radical Biology and Medicine 50, 1488–1491.CrossRefGoogle ScholarPubMed
Brown, NC, Andreazza, AC and Young, LT (2014) An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Research 218, 61–68.CrossRefGoogle ScholarPubMed
Church, TS, Earnest, CP, Skinner, JS and Blair, SN (2007) Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial. JAMA 297, 2081–2091.CrossRefGoogle ScholarPubMed
Conn, VS (2010) Depressive symptom outcomes of physical activity interventions: meta-analysis findings. Annals of Behavioral Medicine 39, 128–138.CrossRefGoogle ScholarPubMed
Cornier, MA, Despres, JP, Davis, N, Grossniklaus, DA, Klein, S, Lamarche, B, Lopez-Jimenez, F, Rao, G, St-Onge, MP, Towfighi, A and Poirier, P (2011) Assessing adiposity: a scientific statement from the American heart association. Circulation 124, 1996–2019.CrossRefGoogle ScholarPubMed
Czepielewski, L, Daruy Filho, L, Brietzke, E and Grassi-Oliveira, R (2013) Bipolar disorder and metabolic syndrome: a systematic review. Revista Brasileira de Psiquiatria Psychiatry Oficial Journal of the Brazilian Psychiatric Association 35, 88–93.Google ScholarPubMed
Dawson, SL, Dash, SR and Jacka, FN (2016) The importance of diet and Gut health to the treatment and prevention of mental disorders. International Review of Neurobiology 131, 325–346.CrossRefGoogle ScholarPubMed
de Melo, LGP, Nunes, SOV, Anderson, G, Vargas, HO, Barbosa, DS, Galecki, P, Carvalho, AF and Maes, M (2017) Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders. Neuropsychopharmacology & Biological Psychiatry 78, 34–50.CrossRefGoogle ScholarPubMed
Fava, M (2000) Weight gain and antidepressants. Journal of Clinical Psychiatry 61(suppl. 11), 37–41.Google ScholarPubMed
Fernandes, BS, Steiner, J, Molendijk, ML, Dodd, S, Nardin, P, Goncalves, CA, Jacka, F, Kohler, CA, Karmakar, C, Carvalho, AF and Berk, M (2016) C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis. The Lancet. Psychiatry 3, 1147–1156.CrossRefGoogle ScholarPubMed
Goldstein, BI (2017) Bipolar disorder and the vascular system: mechanisms and new prevention opportunities. Canadian Journal of Cardiology 33, 1565–1576.CrossRefGoogle ScholarPubMed
Guha, P, Bhowmick, K, Mazumder, P, Ghosal, M, Chakraborty, I and Burman, P (2014) Assessment of insulin resistance and metabolic syndrome in drug naive patients of bipolar disorder. Indian Journal of Clinical Biochemistry 29, 51–56.CrossRefGoogle ScholarPubMed
Hamilton, M (1967) Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 6, 278–296.CrossRefGoogle ScholarPubMed
Hebebrand, J, Friedel, S, Schauble, N, Geller, F and Hinney, A (2003) Perspectives: molecular genetic research in human obesity. Obesity Reviews 4, 139–146.CrossRefGoogle ScholarPubMed
Henderson, DC, Vincenzi, B, Andrea, NV, Ulloa, M and Copeland, PM (2015) Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses. The Lancet. Psychiatry 2, 452–464.CrossRefGoogle ScholarPubMed
Hiles, SA, Lamers, F, Milaneschi, Y and Penninx, B (2017) Sit, step, sweat: longitudinal associations between physical activity patterns, anxiety and depression. Psychological Medicine 47, 1466–1477.CrossRefGoogle ScholarPubMed
Hruby, A and Hu, FB (2015) The epidemiology of obesity: a big picture. Pharmacoeconomics 33, 673–689.CrossRefGoogle ScholarPubMed
Jacka, FN, O'neil, A, Opie, R, Itsiopoulos, C, Cotton, S, Mohebbi, M, Castle, D, Dash, S, Mihalopoulos, C, Chatterton, ML, Brazionis, L, Dean, OM, Hodge, AM and Berk, M (2017) A randomised controlled trial of dietary improvement for adults with major depression (the ‘SMILES’ trial). BMC Medicine 15, 23.CrossRefGoogle Scholar
Jokela, M, Elovainio, M, Keltikangas-Jarvinen, L, Batty, GD, Hintsanen, M, Seppala, I, Kahonen, M, Viikari, JS, Raitakari, OT, Lehtimaki, T and Kivimaki, M (2012) Body mass index and depressive symptoms: instrumental-variables regression with genetic risk score. Genes Brain and Behavior 11, 942–948.Google ScholarPubMed
Kapczinski, F, Dal-Pizzol, F, Teixeira, AL, Magalhaes, PV, Kauer-Sant'anna, M, Klamt, F, Pasquali, MA, Quevedo, J, Gama, CS and Post, R (2010) A systemic toxicity index developed to assess peripheral changes in mood episodes. Molecular Psychiatry 15, 784–786.CrossRefGoogle ScholarPubMed
Kemp, DE, Gao, K, Chan, PK, Ganocy, SJ, Findling, RL and Calabrese, JR (2010) Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome. Bipolar Disorders 12, 404–413.CrossRefGoogle ScholarPubMed
Kendler, KS, Aggen, SH and Neale, MC (2013) Evidence for multiple genetic factors underlying DSM-IV criteria for major depression. JAMA Psychiatry 70, 599–607.CrossRefGoogle ScholarPubMed
Kessing, LV, Vradi, E and Andersen, PK (2015) Life expectancy in bipolar disorder. Bipolar Disorders 17, 543–548.CrossRefGoogle ScholarPubMed
Kiliaan, AJ, Arnoldussen, IA and Gustafson, DR (2014) Adipokines: a link between obesity and dementia? Lancet Neurology 13, 913–923.CrossRefGoogle ScholarPubMed
Kim, YK, Jung, HG, Myint, AM, Kim, H and Park, SH (2007) Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. Journal of Affective Disorders 104, 91–95.CrossRefGoogle ScholarPubMed
Kjaer, LK, Cejvanovic, V, Henriksen, T, Petersen, KM, Hansen, T, Pedersen, O, Christensen, CK, Torp-Pedersen, C, Gerds, TA, Brandslund, I, Mandrup-Poulsen, T and Poulsen, HE (2017) Cardiovascular and all-cause mortality risk associated with urinary excretion of 8-oxoGuo, a biomarker for RNA oxidation, in patients with type 2 diabetes: a prospective cohort study. Diabetes Care 40, 1771–1778.CrossRefGoogle ScholarPubMed
Kloiber, S, Ising, M, Reppermund, S, Horstmann, S, Dose, T, Majer, M, Zihl, J, Pfister, H, Unschuld, PG, Holsboer, F and Lucae, S (2007) Overweight and obesity affect treatment response in major depression. Biological Psychiatry 62, 321–326.CrossRefGoogle ScholarPubMed
Kohler, CA, Freitas, TH, Maes, M, De Andrade, NQ, Liu, CS, Fernandes, BS, Stubbs, B, Solmi, M, Veronese, N, Herrmann, N, Raison, CL, Miller, BJ, Lanctot, KL and Carvalho, AF (2017) Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatrica Scandinavica 135, 373–387.CrossRefGoogle ScholarPubMed
Krane-Gartiser, K, Breum, L, Glumrr, C, Linneberg, A, Madsen, M, Koster, A, Jepsen, PW and Fink-Jensen, A (2011) Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics. Nordic Journal of Psychiatry 65, 345–352.CrossRefGoogle ScholarPubMed
Kvam, S, Kleppe, CL, Nordhus, IH and Hovland, A (2016) Exercise as a treatment for depression: a meta-analysis. Journal of Affective Disorders 202, 67–86.CrossRefGoogle ScholarPubMed
Landucci Bonifacio, K, Sabbatini Barbosa, D, Gastaldello Moreira, E, De Farias, CC, Higachi, L, Camargo, AEI, Favaro Soares, J, Odebrecht Vargas, H, Nunes, SOV, Berk, M, Dodd, S and Maes, M (2017) Indices of insulin resistance and glucotoxicity are not associated with bipolar disorder or major depressive disorder, but are differently associated with inflammatory, oxidative and nitrosative biomarkers. Journal of Affective Disorders 222, 185–194.CrossRefGoogle ScholarPubMed
Lassale, C, Batty, GD, Baghdadli, A, Jacka, F, Sanchez-Villegas, A, Kivimaki, M and Akbaraly, T (2018) Healthy dietary indices and risk of depressive outcomes: a systematic review and meta-analysis of observational studies. Molecular Psychiatry 24, 965–998.CrossRefGoogle ScholarPubMed
Lauenborg, J, Mathiesen, E, Hansen, T, Glumer, C, Jorgensen, T, Borch-Johnsen, K, Hornnes, P, Pedersen, O and Damm, P (2005) The prevalence of the metabolic syndrome in a Danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. The Journal of Clinical Endocrinology & Metabolism 90, 4004–4010.CrossRefGoogle Scholar
Lee, YA, Kang, SG, Song, SW, Rho, JS and Kim, EK (2015) Association between metabolic syndrome, smoking status and coronary artery calcification. PLoS One 10, e0122430.Google ScholarPubMed
Maes, M, Galecki, P, Chang, YS and Berk, M (2011) A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Progress in Neuropsychopharmacol & Biological Psychiatry 35, 676–692.CrossRefGoogle ScholarPubMed
Mannie, ZN, Williams, C, Diesch, J, Steptoe, A, Leeson, P and Cowen, PJ (2013) Cardiovascular and metabolic risk profile in young people at familial risk of depression. British Journal of Psychiatry 203, 18–23.CrossRefGoogle ScholarPubMed
Mansur, RB, Brietzke, E and Mcintyre, RS (2015) Is there a “metabolic-mood syndrome”? A review of the relationship between obesity and mood disorders. Neuroscience and Biobehavioral Reviews 52, 89–104.CrossRefGoogle Scholar
Matthews, DR, Hosker, JP, Rudenski, AS, Naylor, BA, Treacher, DF and Turner, RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419.CrossRefGoogle ScholarPubMed
Mcintyre, RS, Soczynska, JK, Konarski, JZ and Kennedy, SH (2006) The effect of antidepressants on lipid homeostasis: a cardiac safety concern? Expert Opinion on Drug Safety 5, 523–537.CrossRefGoogle ScholarPubMed
Morris, G, Fernandes, BS, Puri, BK, Walker, AJ, Carvalho, AF and Berk, M (2018) Leaky brain in neurological and psychiatric disorders: drivers and consequences. The Australian and New Zealand Journal of Psychiatry 52, 924–948.CrossRefGoogle ScholarPubMed
Munkholm, K, Brauner, JV, Kessing, LV and Vinberg, M (2013) Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. Journal of Psychiatr Research 47, 1119–1133.CrossRefGoogle ScholarPubMed
Munkholm, K, Poulsen, HE, Kessing, LV and Vinberg, M (2015) Elevated levels of urinary markers of oxidatively generated DNA and RNA damage in bipolar disorder. Bipolar Disorders 17, 257–268.CrossRefGoogle ScholarPubMed
O'neil, A, Jacka, FN, Quirk, SE, Cocker, F, Taylor, CB, Oldenburg, B and Berk, M (2015) A shared framework for the common mental disorders and non-communicable disease: key considerations for disease prevention and control. BMC Psychiatry 15, 15.CrossRefGoogle ScholarPubMed
Osborn, DP, Levy, G, Nazareth, I, Petersen, I, Islam, A and King, MB (2007) Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's general practice research database. Archives of General Psychiatry 64, 242–249.CrossRefGoogle Scholar
Oskooilar, N, Wilcox, CS, Tong, ML and Grosz, DE (2009) Body mass index and response to antidepressants in depressed research subjects. The Journal of Clinical Psychiatry 70, 1609–1610.CrossRefGoogle ScholarPubMed
Ottesen, NM, Meluken, I, Scheike, T, Kessing, LV, Miskowiak, KW and Vinberg, M (2018) Clinical characteristics, life adversities and personality traits in monozygotic twins with, at risk of and without affective disorders. Frontiers in Psychiatry 9, 401.CrossRefGoogle ScholarPubMed
Pan, A, Keum, N, Okereke, OI, Sun, Q, Kivimaki, M, Rubin, RR and Hu, FB (2012) Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care 35, 1171–1180.CrossRefGoogle ScholarPubMed
Park, YW, Zhu, S, Palaniappan, L, Heshka, S, Carnethon, MR and Heymsfield, SB (2003) The metabolic syndrome: prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988–1994. Archives of Internal Medicine 163, 427–436.CrossRefGoogle ScholarPubMed
Patten, SB, Williams, JVA, Lavorato, DH, Wang, JL, Jette, N, Sajobi, TT, Fiest, KM and Bulloch, AGM (2018) Patterns of association of chronic medical conditions and major depression. Epidemiology and Psychiatric Sciences 27, 42–50.CrossRefGoogle ScholarPubMed
Penninx, B and Lange, SMM (2018) Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications. Dialogues in Clinical Neuroscience 20, 63–73.Google ScholarPubMed
Ramasubbu, R (2002) Insulin resistance: a metabolic link between depressive disorder and atherosclerotic vascular diseases. Medical Hypotheses 59, 537–551.CrossRefGoogle ScholarPubMed
Rasmussen, ST, Andersen, JT, Nielsen, TK, Cejvanovic, V, Petersen, KM, Henriksen, T, Weimann, A, Lykkesfeldt, J and Poulsen, HE (2016) Simvastatin and oxidative stress in humans: a randomized, double-blinded, placebo-controlled clinical trial. Redox Biology 9, 32–38.CrossRefGoogle ScholarPubMed
Rethorst, CD, Bernstein, I and Trivedi, MH (2014) Inflammation, obesity, and metabolic syndrome in depression: analysis of the 2009–2010 national health and nutrition examination survey (NHANES). The Journal of Clinical Psychiatry 75, e1428–e1432.CrossRefGoogle Scholar
Rivera, M, Cohen-Woods, S, Kapur, K, Breen, G, Ng, MY, Butler, AW, Craddock, N, Gill, M, Korszun, A, Maier, W, Mors, O, Owen, MJ, Preisig, M, Bergmann, S, Tozzi, F, Rice, J, Rietschel, M, Rucker, J, Schosser, A, Aitchison, KJ, Uher, R, Craig, IW, Lewis, CM, Farmer, AE and Mcguffin, P (2012) Depressive disorder moderates the effect of the FTO gene on body mass index. Molecular Psychiatry 17, 604–611.CrossRefGoogle ScholarPubMed
Rosenbaum, S, Tiedemann, A, Sherrington, C, Curtis, J and Ward, PB (2014) Physical activity interventions for people with mental illness: a systematic review and meta-analysis. The Journal of Clinical Psychiatry 75, 964–974.CrossRefGoogle ScholarPubMed
Samaan, Z, Anand, SS, Zhang, X, Desai, D, Rivera, M, Pare, G, Thabane, L, Xie, C, Gerstein, H, Engert, JC, Craig, I, Cohen-Woods, S, Mohan, V, Diaz, R, Wang, X, Liu, L, Corre, T, Preisig, M, Kutalik, Z, Bergmann, S, Vollenweider, P, Waeber, G, Yusuf, S and Meyre, D (2013) The protective effect of the obesity-associated rs9939609 a variant in fat mass- and obesity-associated gene on depression. Molecular Psychiatry 18, 1281–1286.CrossRefGoogle ScholarPubMed
Sari-Sarraf, V, Aliasgarzadeh, A, Naderali, MM, Esmaeili, H and Naderali, EK (2015) A combined continuous and interval aerobic training improves metabolic syndrome risk factors in men. International Journal of General Medicine 8, 203–210.Google ScholarPubMed
Schuch, FB, Vancampfort, D, Firth, J, Rosenbaum, S, Ward, PB, Silva, ES, Hallgren, M, Ponce De Leon, A, Dunn, AL, Deslandes, AC, Fleck, MP, Carvalho, AF and Stubbs, B (2018) Physical activity and incident depression: a meta-analysis of prospective cohort studies. The American Journal of Psychiatry 175, 631–648.CrossRefGoogle ScholarPubMed
Shelton, RC and Miller, AH (2010) Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Progress in Neurobiology 91, 275–299.CrossRefGoogle ScholarPubMed
Smoller, JW and Finn, CT (2003) Family, twin, and adoption studies of bipolar disorder. American Journal of Medical Genetics. Part C Seminar of Medical Genetics 123C, 48–58.CrossRefGoogle ScholarPubMed
Stunkard, AJ, Foch, TT and Hrubec, Z (1986) A twin study of human obesity. JAMA 256, 51–54.CrossRefGoogle ScholarPubMed
Sublette, ME and Postolache, TT (2012) Neuroinflammation and depression: the role of indoleamine 2,3-dioxygenase (IDO) as a molecular pathway. Psychosomatic Medicine 74, 668–672.CrossRefGoogle Scholar
Sullivan, PF, Neale, MC and Kendler, KS (2000) Genetic epidemiology of major depression: review and meta-analysis. The American Journal of Psychiatry 157, 1552–1562.CrossRefGoogle ScholarPubMed
Sun, K, Liu, J and Ning, G (2012) Active smoking and risk of metabolic syndrome: a meta-analysis of prospective studies. PLoS ONE 7, e47791.Google ScholarPubMed
Taylor, G, Mcneill, A, Girling, A, Farley, A, Lindson-Hawley, N and Aveyard, P (2014) Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ 348, g1151.CrossRefGoogle ScholarPubMed
Valkanova, V, Ebmeier, KP and Allan, CL (2013) CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. Journal of Affective Disorders 150, 736–744.CrossRefGoogle ScholarPubMed
Vancampfort, D, Correll, CU, Wampers, M, Sienaert, P, Mitchell, AJ, De Herdt, A, Probst, M, Scheewe, TW and De Hert, M (2014) Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables. Psychological Medicine 44, 2017–2028.CrossRefGoogle ScholarPubMed
Vancampfort, D, Stubbs, B, Mitchell, AJ, De Hert, M, Wampers, M, Ward, PB, Rosenbaum, S and Correll, CU (2015) Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry 14, 339–347.CrossRefGoogle ScholarPubMed
Visser, M, Bouter, LM, Mcquillan, GM, Wener, MH and Harris, TB (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282, 2131–2135.CrossRefGoogle ScholarPubMed
Wallace, TM, Levy, JC and Matthews, DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27, 1487–1495.CrossRefGoogle ScholarPubMed
Wing, JK, Babor, T, Brugha, T, Burke, J, Cooper, JE, Giel, R, Jablenski, A, Regier, D and Sartorius, N (1990) SCAN. Schedules for clinical assessment in neuropsychiatry. Archives of General Psychiatry 47, 589–593.CrossRefGoogle ScholarPubMed
Young, RC, Biggs, JT, Ziegler, VE and Meyer, DA (1978) A rating scale for mania: reliability, validity and sensitivity. The British Journal of Psychiatry 133, 429–435.CrossRefGoogle ScholarPubMed
Zerati, AE, Monteiro Guimaraes, AL, Miranda De Carvalho, HA, Saes, GF, Ragazzo, L, Wolosker, N and De Luccia, N (2014) Influence of criteria used in determining prevalence of metabolic syndrome (NCEP-ATPIII versus IDF) in patients with intermittent claudication. Annals of Vascular Surgery 28, 640–643.CrossRefGoogle ScholarPubMed